Nigeria

in page functions
[French]
Nigeria
Total population (2017) 191,835,907
Birth cohort (2017) 7,322,279
Surviving Infants (surviving to 1 year per year, 2017) 6,822,481
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 69/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 109/1000
World Bank Index, IDA (2015) 3.41
Gross Nation Income (per capita US$, 2015) 2,820
Co-financing group (2017) Accelerated transition
No. of districts/territories (2015) 774

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Nigeria

Type of support

Approvals

2001-2021 (US$)
(25 Apr 2017)

Commitments

2001-2021 (US$)
(25 Apr 2017)

Disbursements

2000-2017 (US$)
(25 Apr 2017)

% Disbursed

(25 Apr 2017)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $747,990,618 $980,228,618 $692,878,676
Health system strengthening (HSS 1) $42,504,000 $42,504,000 $40,238,758 95%
Immunisation services support (ISS) $47,324,000 $47,324,000 $47,324,000 100%
Injection Safety Devices (NVS) $1,766,000 $4,743,000 $2,206,852 125%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $28,626,714 $28,626,714 $24,845,280 87%
Measles SIA (NVS) $22,491,870 $22,491,870 $22,604,288 100%
Measles SIA - Operational costs (OPC) $39,423,500 $39,423,500 $39,423,500 100%
Meningitis A (NVS) $4,863,000 $14,040,500
Meningitis A - campaign (NVS) $55,966,777 $55,966,777 $56,057,711 100%
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $149,981,711 $189,536,711 $133,780,111 89%
Pneumo (NVS) $192,832,878 $322,573,378 $182,298,122 95%
Rotavirus (NVS) $50,788,000 N/A
Vaccine Introduction Grant (VIG) $15,861,921 $15,861,921 $14,176,839 89%
Yellow Fever (NVS) $39,012,946 $39,012,946 $39,711,793 102%
Yellow Fever - campaign (NVS) $32,627,883 $32,627,883 $27,600,556 85%
YF - Operational costs (OPC) $18,571,500 $18,571,500 $6,495,000 35%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 74%
M:F sex ratio at birth (2017) 1.06
Household survey: DTP3 coverage for male (2012) 39.40%
Household survey: DTP3 coverage for female (2012) 37.00%
Household survey: Last DTP3 survey (2012) 38%
% districts achieving > 80% DTP3 coverage (2015) 80%
% districts achieving < 50% DTP3 coverage (2015) 2%
MCV WHO/UNICEF estimates (2015) 54%

Breakdown of support

Non-vaccine support Vaccine support
29% 71%
$203,773,963 $489,104,713

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

10 November 2016

Tanzania

Measles jab saves over 20 million young lives in 15 years, but hundreds of children still die of the disease every day

Measles outbreaks in numerous countries – caused by gaps in routine immunisation and in mass vaccination campaigns – continue to be a serious challenge.

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

close icon

modal window here